Cosmos Health COSM
NASDAQ COSM
$3.24 +3.03 (+1,442.86%)
At close: Nov 13, 2026 · 4:00 PM EST

Cosmos Health (COSM) Gains from Sales and Divestitures (2017 - 2018)

Updated

Cosmos Health (COSM) posted Gains from Sales and Divestitures of -$293,294 for Q4 2018.

Analysis

Cosmos Health (COSM) Gains from Sales and Divestitures (2017 - 2018) Analysis & Trends

For FY2018, Cosmos Health's Gains from Sales and Divestitures came in at -$146,647.

  • In prior years, Cosmos Health's Gains from Sales and Divestitures was -$1.95 million in FY2017.
  • The Q4 2018 figure stands as the highest quarterly Gains from Sales and Divestitures since Q1 2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn
10 Cosmos Health 9.71 Mn 5.64 Mn 1.51 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 -293,294.00
Jun 30, 2017 -3.90 Mn
Mar 31, 2017 1.95 Mn
API Access

Cosmos Health Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=COSM&period=max&api_key=YOUR_API_KEY